Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2021 Filed Oct 5, 2021 15:13 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 3,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026613 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,884.4868 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:15 UTC |
Coombe Gary ACEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 83,641 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026614 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,641 Underlying: Common Stock · 83,641 shares Expires 2031-10-01 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:35 UTC |
TASTAD CAROLYN MCEO - Health Care
|
GrantStock Option (Right to Buy) · Derivative | 72,862 | $0.00 Strike: $145.12 | $0.00 |
DisclosureSEC source: 0001127602-21-025393 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,862 Underlying: Common Stock · 72,862 shares Expires 2031-09-15 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:04 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 14,258 | $0.00 Strike: $145.12 | $0.00 |
DisclosureSEC source: 0001127602-21-025391 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,258 Underlying: Common Stock · 14,258 shares Expires 2031-09-15 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:43 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 154,226 | $0.00 Strike: $145.12 | $0.00 |
DisclosureSEC source: 0001127602-21-025394 · form4.xml · derivative · entry 3 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,226 Underlying: Common Stock · 154,226 shares Expires 2031-09-15 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:44 UTC |
Jejurikar ShaileshCEO - Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 75,791 | $0.00 Strike: $145.12 | $0.00 |
DisclosureSEC source: 0001127602-21-025395 · form4.xml · derivative · entry 4 Jejurikar Shailesh · CIK 0001746310 · CEO - Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,791 Underlying: Common Stock · 75,791 shares Expires 2031-09-15 Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:26 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025296 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560.93 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:28 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 241 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025297 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,437.4628 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:30 UTC |
Chang AmyDirector
|
GrantCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025299 · form4.xml · nonDerivative · entry 1 Chang Amy · CIK 0001551504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,203.783 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:31 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 241 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025300 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,138.739 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:32 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025302 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,159.417 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:34 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025303 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,798.206 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:35 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 258 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025304 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,887.717 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:37 UTC |
BLAKE FRANCIS SDirector
|
GrantCommon Stock | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025305 · form4.xml · nonDerivative · entry 1 BLAKE FRANCIS S · CIK 0001194702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,133.733 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 19:38 UTC |
MCNERNEY W JAMES JRDirector
|
GrantCommon Stock | 276 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025307 · form4.xml · nonDerivative · entry 1 MCNERNEY W JAMES JR · CIK 0001182055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,966.068 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:50 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 56,818 | $143.15 | $8,133,769.43 |
DisclosureSEC source: 0001209191-21-054533 · doc4.xml · nonDerivative · entry 2 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 5,264,066 F1 · kind: The sales reported in this Form 4 were done for portfolio management purposes. F5 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $143.01 to $143.34. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P. and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:50 UTC |
PELTZ NELSONDirector
TRIAN FUND MANAGEMENT, L.P.Director
|
SaleCommon Stock | 150,182 | $142.15 | $21,348,416.35 |
DisclosureSEC source: 0001209191-21-054533 · doc4.xml · nonDerivative · entry 1 PELTZ NELSON · CIK 0000928265 · Director TRIAN FUND MANAGEMENT, L.P. · CIK 0001345471 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Please see explanation below Disclosed balance after: 5,320,884 F1 · kind: The sales reported in this Form 4 were done for portfolio management purposes. F2 · price: The price shown in Column 4 is a weighted average sale price. The price range for the sale is $142.05 to $142.24. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Trian Fund Management, L.P. ("Trian Management") serves as the management company for Trian Partners, L.P., Trian Partners Master Fund, L.P., Trian Partners Parallel Fund I, L.P., Trian Partners Strategic Investment Fund-A, L.P., Trian Partners Strategic Investment Fund-N, L.P., Trian Partners Strategic Investment Fund-D, L.P., Trian Partners Fund (Sub)-G, L.P., Trian Partners Strategic Fund-G II, L.P., Trian Partners Strategic Fund G-III, L.P., Trian Partners Strategic Fund-K, L.P. and Trian Partners Co-Investment Opportunities Fund, Ltd. (collectively, the "Trian Entities") and as such determines the investment and voting decisions of the Trian Entities with respect to the shares of the Issuer held by them. F4 · ownership.nature: (FN 3, contd.) Mr. Peltz is a member of Trian Fund Management GP, LLC, which is the general partner of Trian Management, and therefore is in a position to determine the investment and voting decisions made by Trian Management on behalf of the Trian Entities. Accordingly, Mr. Peltz and Trian Management may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the shares beneficially owned by the Trian Entities. The Reporting Persons disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein and this report shall not be deemed an admission that the Reporting Persons are the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Peltz is a director of the Issuer. Read SEC document |
| August 23, 2021 Filed Aug 23, 2021 18:43 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,513 | $144.50 | $218,628.50 |
DisclosureSEC source: 0001127602-21-024157 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,065.7766 Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 18:45 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $85.13 | $0.00 |
DisclosureSEC source: 0001127602-21-024158 · form4.xml · derivative · entry 5 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,337 Underlying: Common Stock · 20,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 18:45 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 20,000 | $145.22 | $2,904,366.00 |
DisclosureSEC source: 0001127602-21-024158 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,835 F1 · price: Weighted average price of the shares sold. The price range was $145.20 to $145.261. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 18:45 UTC |
Coombe Gary ACEO - Grooming
|
Exercise / conversionCommon Stock | 20,000 | $85.13 | $1,702,600.00 |
DisclosureSEC source: 0001127602-21-024158 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 22:46 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
SaleCommon Stock | 8,704 | $144.24 | $1,255,484.98 |
DisclosureSEC source: 0001127602-21-024060 · form4.xml · nonDerivative · entry 3 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,953.368 F5 · price: Weighted average price of the shares sold. The price range was $143.3291 to $144.83. Full information regarding the number off shares sold at each separate price available upon request. Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:24 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 3,703 | $145.00 | $536,935.00 |
DisclosureSEC source: 0001127602-21-024063 · form4.xml · nonDerivative · entry 3 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,008.38 Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:36 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 15,355 | $143.27 | $2,199,910.85 |
DisclosureSEC source: 0001127602-21-024065 · form4.xml · nonDerivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,472.4868 Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:36 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 967 | $143.27 | $138,542.09 |
DisclosureSEC source: 0001127602-21-024065 · form4.xml · nonDerivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 5,935.7842 Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:37 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
SaleCommon Stock | 1,558 | $144.39 | $224,952.92 |
DisclosureSEC source: 0001127602-21-024066 · form4.xml · nonDerivative · entry 3 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,914.1856 Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:38 UTC |
TASTAD CAROLYN MCEO - Health Care
|
SaleCommon Stock | 15,456 | $143.90 | $2,224,118.40 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,497.3632 Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:40 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
SaleCommon Stock | 14,299 | $145.20 | $2,076,180.48 |
DisclosureSEC source: 0001127602-21-024068 · form4.xml · nonDerivative · entry 3 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,668.5285 F5 · price: Weighted average price of the shares sold. The price range was $145.18 to $145.24. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 18:40 UTC |
Moeller Jon RVice Chairman and COO
|
OtherSeries A Preferred Stock · Derivative | 7,736.0413 | $144.52 | $1,118,007.27 |
DisclosureSEC source: 0001127602-21-024156 · form4.xml · derivative · entry 7 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse, By Retirement Plan Trustees Disclosed balance after: 0 Underlying: Common Stock · 7,736.0413 shares Expires not disclosed F6 · derivative.exercise_price: $144.5193 F1 · kind: Preferred Stock converted to Common Stock at market price of Common Stock as part of discretionary disposition from employee benefits plan. F5 · derivative.exercise_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. F5 · derivative.expiration_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 18:40 UTC |
Moeller Jon RVice Chairman and COO
|
OtherCommon Stock | 7,736.0413 | $144.52 | $1,118,007.27 |
DisclosureSEC source: 0001127602-21-024156 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Vice Chairman and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 35,661.0276 F1 · kind: Preferred Stock converted to Common Stock at market price of Common Stock as part of discretionary disposition from employee benefits plan. F2 · balance_after: Immediately following the conversion of Preferred Stock, 29,019 shares of Common Stock previously held through the Company's employee benefit plan were rolled over into an IRA. Fractional share was converted to cash at conversion price. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 21:03 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 40,106 | $144.01 | $5,775,624.95 |
DisclosureSEC source: 0001127602-21-024053 · form4.xml · nonDerivative · entry 4 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,307.6007 F5 · price: Weighted average price of the shares sold. The price range was $143.28 to $144.7785. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:03 UTC |
Taylor David SDirector · Chairman, President & CEO
|
SaleCommon Stock | 53,477 | $144.37 | $7,720,527.97 |
DisclosureSEC source: 0001127602-21-024053 · form4.xml · nonDerivative · entry 3 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,413.6007 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:03 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GrantCommon Stock | 118,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024053 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,890.6007 F2 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:03 UTC |
Taylor David SDirector · Chairman, President & CEO
|
GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024053 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,307.6007 F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:52 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,010 | $144.37 | $145,814.71 |
DisclosureSEC source: 0001127602-21-024056 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,578.7766 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:52 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 2,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024056 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,588.7766 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 22:46 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
SaleCommon Stock | 7,150 | $144.37 | $1,032,252.65 |
DisclosureSEC source: 0001127602-21-024060 · form4.xml · nonDerivative · entry 2 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,657.368 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 22:46 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantCommon Stock | 15,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024060 · form4.xml · nonDerivative · entry 1 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,807.368 F1 · price: Stock Award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:24 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
SaleCommon Stock | 9,726 | $144.37 | $1,404,152.35 |
DisclosureSEC source: 0001127602-21-024063 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,711.38 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:24 UTC |
Francisco Ma. FatimaCEO - Baby & Feminine Care
|
GrantCommon Stock | 25,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024063 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby & Feminine Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,437.38 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:32 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 12,006 | $144.37 | $1,733,318.23 |
DisclosureSEC source: 0001127602-21-024064 · form4.xml · nonDerivative · entry 2 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,835 F2 · shares: Shares sold to cover taxes on Stock Award. F3 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:32 UTC |
Coombe Gary ACEO - Grooming
|
GrantCommon Stock | 25,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024064 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,841 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:36 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 13,325 | $144.37 | $1,923,743.58 |
DisclosureSEC source: 0001127602-21-024065 · form4.xml · nonDerivative · entry 4 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,827.4868 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:36 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 28,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024065 · form4.xml · nonDerivative · entry 3 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,152.4868 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:36 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 840 | $144.37 | $121,271.64 |
DisclosureSEC source: 0001127602-21-024065 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 6,902.7842 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:36 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 1,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024065 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,742.7842 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:37 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
SaleCommon Stock | 667 | $144.37 | $96,295.46 |
DisclosureSEC source: 0001127602-21-024066 · form4.xml · nonDerivative · entry 2 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,472.1856 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:37 UTC |
Homan Michael G.SVP - Chief Accounting Officer
|
GrantCommon Stock | 2,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024066 · form4.xml · nonDerivative · entry 1 Homan Michael G. · CIK 0001847579 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,139.1856 F1 · price: Stock award pursuant to issuer's 2019 stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:38 UTC |
TASTAD CAROLYN MCEO - Health Care
|
SaleCommon Stock | 12,696 | $144.37 | $1,832,934.22 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,953.3632 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:38 UTC |
TASTAD CAROLYN MCEO - Health Care
|
GrantCommon Stock | 28,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,649.3632 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.